References
- Wright CG, Meyerhoff WL. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Am J Otolaryngol 1984; 5: 166–76.
- Wright CG, Halama AR, Meyerhoff WL. Ototoxicity of an ototopical preparation in a primate. Am J Otol 1987; 8: 56–60.
- Wright CG, Meyerhoff WL, Halama AR. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol 1987; 8: 495–9.
- Harada T, Iwamori M, Nagai Y, Nomura Y. Ototoxic-ity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhi-nol Laryngol 1986; 95: 404–8.
- Barlow DW, Duckert LG, Kreig CS, Gates GA. Oto-toxicity of topical otomicrobial agents. Acta Otolaryn-gol (Stockh) 1994; 115: 231–5.
- Tong MCF, Woo JKS, van Hasselt CA. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media. J Laryngol Otol 1996; 110: 309–14.
- Morizono T. Toxicity of ototopical drugs: animal mod-eling. Ann Otol Rhinol Laryngol Suppl 1990; 148: 42–5.
- Ikiz AO, Serbetcioglu B, Guneri EA, Sutay S, Ceryan K. Investigation of topical ciprofloxacin ototoxicity in guinea pigs. Acta Otolaryngol (Stockh) 1998; 118: 808–12.
- Claes J, Govaerts PJ, van de Heyning PH, Peeters S. Lack of ciprofloxacin ototoxicity after repeated oto-topical application. Antimicrob Agents Chemother 1991; 35: 1014–6.
- Brownlee RE, Hulka GF, Prazma J, Pillsbury HC, III. Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992; 118: 392–6.
- Bagger-Sjoback D, Lundman L, Nilsson-Ehle I. Ciprofloxacin and the inner ear—a morphological and round window membrane permeability study. ORL J Otorhinolaryngol Relat Spec 1992; 54: 5–9.
- Dohar JE, Alper CM, Casselbrant ML, et al. Treat-ment of chronic suppurative otitis media with topical ciprofloxacin. Ann Otol Rhinol Laryngol 1998; 107: 865 —71.
- Ozagar A, Koc A, Ciprut A, Tutkun A, Akdas F, Sehitoglu MA. Effects of topical otic preparations on hearing in chronic otitis media. Otolaryngol Head Neck Surg 1997; 117: 405–8.
- Goycoolea MV, Lundman L. Round window mem-brane. Structure function and permeability: a review. Microsc Res Tech 1997; 36: 201–11.
- Ikeda K, Morizono T. Round window membrane per-meability during experimental purulent otitis media:altered Cortisporin ototoxicity. Ann Otol Rhinol Laryngol 1990; 99: 46–8.
- Engel F, Blatz R, Kellner J, Palmer M, Weller U, Bhakdi S. Breakdown of the round window membrane permeability barrier evoked by streptolysin 0: possible etiologic role in development of sensorineural hearing loss in acute otitis media. Infect Immunol 1995; 63: 1305–10.
- Smith BM, Myers MG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg 1979; 87: 888–91.
- Schuknecht HF. Ablation therapy in the management of Ménière's disease. Acta Otolaryngol (Stockh) 1957; 132: 1–42.
- Silverstein H, Arruda J, Rosenberg SI, Deems D, Hes-ter TO. Direct round window membrane application of gentamicin in the treatment of Méniere's disease. Oto-laryngol Head Neck Surg 1999; 120: 649–55.
- Brownell WE. Outer hair cell electromotility and otoa-coustic emissions. Ear Hear 1990; 11: 82–92.
- Simpson KL, Markham A. Ofloxacin otic solution. A review of its use in the management of ear infections. Drugs 1999; 58: 509–31.